HOME >> BIOLOGY >> NEWS
Genomic data viewed on biological pathways with new computer program, GenMAPP

and Gladstone postodoctoral fellow. "The long-term goal is to have MAPPs representing all biological pathways so we can use a systems approach to analyze gene expression data and thus see the big picture."

The most widespread method of analyzing gene expression data is called hierarchical clustering, which groups together genes with similar levels of expression. This method is powerful because it groups genes together without any prior knowledge of the genes function. GenMAPP takes an opposite, complementary approach. By looking at genes in the context of a known biological process, it is possible to make sense of data that would otherwise be uninterpretable.

Furthermore, small changes in gene expression may be missed in hierarchical clustering, yet have real meaning when displayed on a biological pathway. Hierarchical clustering and the pathway-based GenMAPP work together to help in interpreting biological data.

"This is part of a larger process of putting all the pieces together and has tremendous value for figuring out diseases," Conklin said.

Currently GenMAPP is the only free available program for drawing, viewing, and sharing pathway information in a format that can be used with gene expression data. There are no barriers for any scientist to use the program to modify MAPPs according to his or her hypothesis, to design new pathways and to share the data with others in the community. Conklin said that he hopes that GenMAPP becomes a standard means of viewing microarray data, and pathway information. Already, researchers are using GenMAPP to display results in conferences and published papers. By providing a common format to present and share data, Conklin said that he hopes that GenMAPP will help biologists communicate.

"This puts us one step closer to a common goal of trying to determine how we put all the pieces of the biological puzzle together," he said.


'"/>

Contact: Laura Lane
llane@gladstone.ucsf.edu
415-695-3833
University of California - San Francisco
6-May-2002


Page: 1 2 3

Related biology news :

1. NIH launches first center in Nationwide Chemical Genomics Network
2. Genomic biology institutes first grant to focus on soybeans, climate change
3. Genomic imprinting in disruptive spermatogenesis
4. Genomic changes reveal evolution of SARS virus
5. Evolutionary Genomics meeting in Tucson
6. New Columbia Genomic Center of Excellence aims to speed genetic targeting of medicines
7. Monitoring malaria: Genomic activity of the parasite in human blood cells
8. On tap: Genomic sequence of an enemy of beer and bread
9. Moffitt Cancer Center receives DoD funds to establish National Functional Genomics Project
10. Genomics and world peace
11. Consortium for Archaeal Genomics and Proteomics established at Penn State

Post Your Comments:
(Date:12/10/2014)...  Valencell, a leader in performance biometric data sensor ... from its licensees for highly accurate, clinically validated biometric ... coming from fitness and health sectors, but first responders/military ... is only as useful as the biometric data it ... in long-term mass consumer adoption of wearable products," said ...
(Date:12/5/2014)... Calif. , Dec. 4, 2014 ... has boosted investments in new testing and inspection ... also given rise to a range of innovative ... the requirements of Generation Y, which is generally ... As a result, product development strategies of test ...
(Date:11/21/2014)... 18, 2014 According to a ... Systems (Video, RFID, Access Control, Intrusion Detection, Parking Management, ... Government), Component Service Geography - Global Forecasts to 2020", ... projected to be around $25 Billion in 2014 and ... at a CAGR of 8.69%. Browse 116 ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
(Date:12/17/2014)... 17, 2014 Ipsen Biopharmaceuticals, Inc., ... ADR: IPSEY), today announced that Somatuline® ... Somatuline®) was approved by the U.S. Food and ... neuroendocrine tumors (GEP-NETs) in adult patients with unresectable, ... disease to improve progression-free survival (PFS). , “The ...
(Date:12/17/2014)... 17, 2014 This report is ... Tubing industry. For an overview analysis, the report ... industry chain structure, industry overview, policy analysis, and ... industry has witnessed rapid development with key ... acquisitions. This report mentions quartz tubing upstream raw ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... on gynecologic disease, today announced the next step in ... premier bio-analytics solutions provider with the naming of current ... and Chief Executive Officer, while current Chairman of the ... to serve as Chairman. These changes are effective January ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 82020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4
Cached News: